NEJM December 6, 2025
Joshua D. Wallach, Ph.D., Joseph S. Ross, M.D., M.H.S., and Reshma Ramachandran, M.D., M.P.P., M.H.S.

Abstract

The FDA recently announced that it will be releasing daily drug adverse-event data. But questions...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 1)

Share Article